Once you've read the case and think you have the answer, click the answer button. When the question page reloads, scroll down the page and the full answer and explanation will be revealed under the question text.
A 23-year-old male presents with fever, sore throat and malaise and is diagnosed with infectious mononucleosis. He subsequently returns and requires admission for splenomegaly, hemolytic anemia, thrombocytopenia, aplastic anemia, and significant tonsillar enlargement with airway compromise (see image below). He is ill and obviously deteriorating.
Which statement correctly describes a treatment option for severe infectious mononucleosis?
a) In patients with severe mononucleosis, valacyclovir therapy decreases the risk of fulminant viremia, splenic rupture, cardiovascular collapse, and death.
b) Corticosteroids may be helpful in the management of the upper-airway obstruction, hemolytic anemia, and thrombocytopenia associated with severe infectious mononucleosis.
c) Acyclovir has been shown to reduce the severity of symptoms and to shorten the hospital stay by 20% in severe mononucleosis cases.
d) Etoposide reduces the incidence of shock in patients with severe infectious mononucleosis.
e) Preliminary studies show that treatment with zanamivir decreases the need for advanced airway management in hospitalized patients with severe mononucleosis.
Evidence suggests that continued clinical education and frequent review improves care. A Challenger program provides ongoing peer-reviewed cases and questions that come as you need them. Assess completely with our Board Exam Simulator. Receive instant feedback and a learning path. Boost retention. Learn faster. It's the science of education - for the clinical mind.
Enter the Store Try a Free DemoCall 1-888-242-5536 or Contact our Support Department for free live US-based support, weekdays, Mon-Fri, 8am-6pm CT. You can even schedule an online remote support session.
Access the Support ForumAccess our Online Support Forum to report issues (create a support ticket), find ready answers to FAQ's and troubleshooting issues in our searchable forum database, view tutorials, and more.
Challenger's CEO, Bob Sweeney, talks about the Challenger Program for Residencies (CPR)
Get a free clinical case Q&A emailed to you twice a month. It's fun, free, and informative. |